de Ameriprise United Therapeutics UTHR Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 66.8 M | Comprar |
123,215
+31,990
| +35% | +USD 18 M | 0.01% | 795 |
|
|
2026
Q1 | USD 54.1 M | Vender |
91,225
-9,817
| -10% | -USD 4.89 M | 0.01% | 834 |
|
|
2025
Q4 | USD 49.2 M | Comprar |
101,042
+37,661
| +59% | +USD 17.5 M | 0.01% | 888 |
|
|
2025
Q3 | USD 26.6 M | Comprar |
63,381
+3,660
| +6% | +USD 1.23 M | 0.01% | 1211 |
|
|
2025
Q2 | USD 17.2 M | Vender |
59,721
-6,509
| -10% | -USD 1.95 M | ﹤0.01% | 1446 |
|
|
2025
Q1 | USD 20.4 M | Vender |
66,230
-658
| -1% | -USD 225 k | 0.01% | 1299 |
|
|
2024
Q4 | USD 23.6 M | Comprar |
66,888
+19
| +0% | +USD 6.98 k | 0.01% | 1228 |
|
|
2024
Q3 | USD 24 M | Vender |
66,869
-6,428
| -9% | -USD 2.17 M | 0.01% | 1222 |
|
|
2024
Q2 | USD 23.4 M | Comprar |
73,297
+2,301
| +3% | +USD 609 k | 0.01% | 1182 |
|
|
2024
Q1 | USD 16.3 M | Vender |
70,996
-2,037
| -3% | -USD 460 k | ﹤0.01% | 1434 |
|
|
2023
Q4 | USD 16.1 M | Vender |
73,033
-6,406
| -8% | -USD 1.48 M | ﹤0.01% | 1409 |
|
|
2023
Q3 | USD 17.9 M | Vender |
79,439
-978
| -1% | -USD 225 k | 0.01% | 1296 |
|
|
2023
Q2 | USD 17.8 M | Vender |
80,417
-6,453
| -7% | -USD 1.43 M | 0.01% | 1344 |
|
|
2023
Q1 | USD 19.5 M | Comprar |
86,870
+7,359
| +9% | +USD 1.81 M | 0.01% | 1281 |
|
|
2022
Q4 | USD 22.1 M | Vender |
79,511
-2,786
| -3% | -USD 703 k | 0.01% | 1178 |
|
|
2022
Q3 | USD 17.2 M | Comprar |
82,297
+1,540
| +2% | +USD 344 k | 0.01% | 1276 |
|
|
2022
Q2 | USD 19 M | Vender |
80,757
-1,757
| -2% | -USD 357 k | 0.01% | 1238 |
|
|
2022
Q1 | USD 14.8 M | Vender |
82,514
-1,034
| -1% | -USD 197 k | ﹤0.01% | 1587 |
|
|
2021
Q4 | USD 18.1 M | Comprar |
83,548
+2,151
| +3% | +USD 422 k | 0.01% | 1502 |
|
|
2021
Q3 | USD 15 M | Vender |
81,397
-2,418
| -3% | -USD 476 k | ﹤0.01% | 1501 |
|
|
2021
Q2 | USD 15 M | Vender |
83,815
-72,266
| -46% | -USD 13.8 M | ﹤0.01% | 1573 |
|
|
2021
Q1 | USD 26.1 M | Vender |
156,081
-23,828
| -13% | -USD 3.97 M | 0.01% | 1124 |
|
|
2020
Q4 | USD 27.3 M | Vender |
179,909
-21,544
| -11% | -USD 2.83 M | 0.01% | 1044 |
|
|
2020
Q3 | USD 20.3 M | Comprar |
201,453
+6,334
| +3% | +USD 695 k | 0.01% | 1062 |
|
|
2020
Q2 | USD 23.6 M | Comprar |
195,119
+15,424
| +9% | +USD 1.74 M | 0.01% | 969 |
|
|
2020
Q1 | USD 17 M | Comprar |
179,695
+56,200
| +46% | +USD 5.34 M | 0.01% | 1035 |
|
|
2019
Q4 | USD 10.9 M | Vender |
123,495
-7,326
| -6% | -USD 645 k | ﹤0.01% | 1680 |
|
|
2019
Q3 | USD 10.4 M | Comprar |
130,821
+15,668
| +14% | +USD 1.26 M | ﹤0.01% | 1658 |
|
|
2019
Q2 | USD 8.99 M | Vender |
115,153
-6,975
| -6% | -USD 652 k | ﹤0.01% | 1817 |
|
|
2019
Q1 | USD 14.3 M | Vender |
122,128
-3,261
| -3% | -USD 380 k | 0.01% | 1388 |
|
|
2018
Q4 | USD 13.7 M | Vender |
125,389
-8,673
| -6% | -USD 1.01 M | 0.01% | 1339 |
|
|
2018
Q3 | USD 17.1 M | Comprar |
134,062
+1,581
| +1% | +USD 196 k | 0.01% | 1423 |
|
|
2018
Q2 | USD 15 M | Comprar |
132,481
+3,303
| +3% | +USD 363 k | 0.01% | 1398 |
|
|
2018
Q1 | USD 14.5 M | Vender |
129,178
-40,195
| -24% | -USD 5.11 M | 0.01% | 1357 |
|
|
2017
Q4 | USD 25.1 M | Comprar |
169,373
+2,263
| +1% | +USD 288 k | 0.01% | 938 |
|
|
2017
Q3 | USD 19.6 M | Vender |
167,110
-5,936
| -3% | -USD 758 k | 0.01% | 1051 |
|
|
2017
Q2 | USD 22.4 M | Comprar |
173,046
+27,304
| +19% | +USD 3.41 M | 0.01% | 951 |
|
|
2017
Q1 | USD 19.7 M | Vender |
145,742
-9,220
| -6% | -USD 1.4 M | 0.01% | 1024 |
|
|
2016
Q4 | USD 22.2 M | Comprar |
154,962
+37,341
| +32% | +USD 4.77 M | 0.01% | 932 |
|
|
2016
Q3 | USD 13.9 M | Comprar |
117,621
+2,265
| +2% | +USD 272 k | 0.01% | 1191 |
|
|
2016
Q2 | USD 12.2 M | Comprar |
115,356
+1,995
| +2% | +USD 223 k | 0.01% | 1248 |
|
|
2016
Q1 | USD 12.6 M | Vender |
113,361
-2,642
| -2% | -USD 334 k | 0.01% | 1243 |
|
|
2015
Q4 | USD 18.2 M | Vender |
116,003
-667
| -0.6% | -USD 97.1 k | 0.01% | 976 |
|
|
2015
Q3 | USD 15.3 M | Vender |
116,670
-3,175
| -3% | -USD 509 k | 0.01% | 1122 |
|
|
2015
Q2 | USD 20.8 M | Vender |
119,845
-74,487
| -38% | -USD 13.4 M | 0.01% | 981 |
|
|
2015
Q1 | USD 33.5 M | Comprar |
194,332
+18,001
| +10% | +USD 2.74 M | 0.02% | 705 |
|
|
2014
Q4 | USD 22.8 M | Comprar |
176,331
+58,808
| +50% | +USD 7.58 M | 0.01% | 886 |
|
|
2014
Q3 | USD 15.1 M | Comprar |
117,523
+8,615
| +8% | +USD 888 k | 0.01% | 1140 |
|
|
2014
Q2 | USD 9.6 M | Vender |
108,908
-4,959
| -4% | -USD 477 k | 0.01% | 1570 |
|
|
2014
Q1 | USD 10.7 M | Vender |
113,867
-136,524
| -55% | -USD 14 M | 0.01% | 1450 |
|
|
2013
Q4 | USD 28.3 M | Vender |
250,391
-12,332
| -5% | -USD 1.11 M | 0.02% | 793 |
|
|
2013
Q3 | USD 20.7 M | Comprar |
262,723
+163,336
| +164% | +USD 11.9 M | 0.01% | 971 |
|
|
2013
Q2 | USD 6.54 M | Comprar |
+99,387
| Nuevas | +USD 6.4 M | ﹤0.01% | 1719 |
|
Otros fondos que tienen UTHR en su cartera
Posición de Ameriprise en UTHR: resumen de T2 2026
Ameriprise aumentó su participación en United Therapeutics (UTHR) en 35% durante T2 2026, al comprar aproximadamente USD 18 M y elevar la posición a 123,215 acciones con un valor de USD 66.8 M. La posición representa 0.01% de la cartera y ocupa el puesto #795.
Ameriprise reportó por primera vez una posición en UTHR en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 885 fondos que sigue Wall St. Rank mantienen una posición en UTHR.
- Al cierre de T2 2026, Ameriprise tenía 123,215 acciones de United Therapeutics con un valor de USD 66.8 M.
- Ameriprise compró 31,990 acciones de United Therapeutics en T2 2026, por un monto estimado de USD 18 M.
- United Therapeutics representó 0.01% de la cartera de Ameriprise en T2 2026 y fue su posición número 795.
- Ameriprise reportó por primera vez una posición en United Therapeutics en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 885 fondos que sigue Wall St. Rank tenían United Therapeutics en cartera.
Según el Informe 13F de Ameriprise correspondiente a T2 2026, presentado el 14 ago 2026.